Akorn, Inc. (AKN) Reports 2012 Fourth Quarter and Year-End Financial Results
2/26/2013 6:55:01 AM
Akorn, Inc. (NASDAQ: AKRX), a niche generic pharmaceutical company, today reported financial results for the fourth quarter and year ended December 31, 2012.
Raj Rai, Chief Executive Officer commented, “We achieved record growth in revenues and profits in 2012 as a result of our strategic growth initiatives – acquisitions, revival of products impacted by hospital drug shortages and new product launches.
comments powered by